The Dermatology Digest

MARCH 14, 2025

Novartis is the official first-in-category corporate pharmaceutical partner of the National Football League (NFL). The partnership aims to empower football fans everywhere to make proactive decisions about their health, better understand screening guidelines and create a playbook for a healthier future.

Pharmaceutical 36

Pharmaceutical Partnerships Medical Office 36

The Dermatology Digest

JULY 22, 2024

Launching Uzpruvo at the earliest opportunity in Europe’s largest pharmaceutical markets, promotes access by creating competition,” says STADA CEO Peter Goldschmidt in a news release. Launches in further European countries are scheduled over the coming months, following national price approvals, via a fully European supply chain.

Partnerships 36

Partnerships Pharmaceutical Marketing Office 36

The Dermatology Digest

JANUARY 4, 2024

The clinical results demonstrated that DMB-3115 and its reference product, ustekinumab, are highly similar, and have no clinically meaningful differences in terms of quality, safety and efficacy. As a global subsidiary of Intas Pharmaceuticals, Accord BioPharma will be responsible for U.S. commercialization.

Pharmaceutical 36

Pharmaceutical Partnerships Clinic Safety 36

The Dermatology Digest

FEBRUARY 27, 2024

This approval marks an important milestone for Teva and Alvotech’s partnership to collaborate on seven biosimilars and expand the availability, access, and uptake of biosimilars in the U.S.” where biologics represent well over 40% of all pharmaceutical spending.

Safety 36

Safety Marketing Pharmaceutical Partnerships 36

Aesthetics Advisor

SEPTEMBER 15, 2023

The pharmacology, toxicity, and safety data for NO use in humans has been well-established for decades. Moreover, Glenmark Pharmaceuticals received manufacturing and marketing approval for the Nitric Oxide Nasal Spray (NONS) as part of an accelerated approval process. You can purchase it online on Amazon.com.

Hospital 69

Hospital Clinic Marketing Medical 69

First Derm

NOVEMBER 25, 2023

Relationship impact : honesty and safety measures are key. 20] The American College of Obstetricians and Gynecologists (ACOG) emphasizes the significant morbidity and mortality caused by HPV and strongly recommends HPV vaccination to eligible patients, stressing the benefits and safety of the vaccine. Current pharmaceutical design.

Safety 45

Safety Education Clinic Therapy 45

The Dermatology Digest

MARCH 27, 2025

and Kaken Pharmaceutical Co., This partnership builds on the positive Phase 2 clinical data of ESK-001, our next-generation oral TYK2 inhibitor, supporting our objectives to unlock its full therapeutic potential and ensure ESK-001 is widely accessible to people with immune-mediated disorders around the world. Alumis Inc.

Pharmaceutical 36

Pharmaceutical Portfolios Clinic Safety 36